<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37709742</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>18</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>22</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>14</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Molecular basis of TASL recruitment by the peptide/histidine transporter 1, PHT1.</ArticleTitle><Pagination><StartPage>5696</StartPage><MedlinePgn>5696</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">5696</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-023-41420-5</ELocationID><Abstract><AbstractText>PHT1 is a histidine /oligopeptide transporter with an essential role in Toll-like receptor innate immune responses. It can act as a receptor by recruiting the adaptor protein TASL which leads to type I interferon production via IRF5. Persistent stimulation of this signalling pathway is known to be involved in the pathogenesis of systemic lupus erythematosus (SLE). Understanding how PHT1 recruits TASL at the molecular level, is therefore clinically important for the development of therapeutics against SLE and other autoimmune diseases. Here we present the Cryo-EM structure of PHT1 stabilized in the outward-open conformation. By combining biochemical and structural modeling techniques we propose a model of the PHT1-TASL complex, in which the first 16 N-terminal TASL residues fold into a helical structure that bind in the central cavity of the inward-open conformation of PHT1. This work provides critical insights into the molecular basis of PHT1/TASL mediated type I interferon production.</AbstractText><CopyrightInformation>&#xa9; 2023. Springer Nature Limited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cust&#xf3;dio</LastName><ForeName>T&#xe2;nia F</ForeName><Initials>TF</Initials><AffiliationInfo><Affiliation>Centre for Structural Systems Biology (CSSB), Notkestra&#xdf;e 85, 22607, Hamburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>European Molecular Biology Laboratory (EMBL) Hamburg, Notkestra&#xdf;e 85, 22607, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Killer</LastName><ForeName>Maxime</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centre for Structural Systems Biology (CSSB), Notkestra&#xdf;e 85, 22607, Hamburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>European Molecular Biology Laboratory (EMBL) Hamburg, Notkestra&#xdf;e 85, 22607, Hamburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Collaboration for joint PhD degree between EMBL, and Heidelberg University, Faculty of Biosciences, 69120, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Dingquan</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-4781-1022</Identifier><AffiliationInfo><Affiliation>Centre for Structural Systems Biology (CSSB), Notkestra&#xdf;e 85, 22607, Hamburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>European Molecular Biology Laboratory (EMBL) Hamburg, Notkestra&#xdf;e 85, 22607, Hamburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Collaboration for joint PhD degree between EMBL, and Heidelberg University, Faculty of Biosciences, 69120, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Puente</LastName><ForeName>Virginia</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Centre for Structural Systems Biology (CSSB), Notkestra&#xdf;e 85, 22607, Hamburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>European Molecular Biology Laboratory (EMBL) Hamburg, Notkestra&#xdf;e 85, 22607, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teufel</LastName><ForeName>Daniel P</ForeName><Initials>DP</Initials><AffiliationInfo><Affiliation>Boehringer Ingelheim Pharma, Birkendorferstra&#xdf;e 65, 88397, Biberach, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pautsch</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Boehringer Ingelheim Pharma, Birkendorferstra&#xdf;e 65, 88397, Biberach, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schnapp</LastName><ForeName>Gisela</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-1529-0130</Identifier><AffiliationInfo><Affiliation>Boehringer Ingelheim Pharma, Birkendorferstra&#xdf;e 65, 88397, Biberach, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grundl</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Boehringer Ingelheim Pharma, Birkendorferstra&#xdf;e 65, 88397, Biberach, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kosinski</LastName><ForeName>Jan</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-3641-0322</Identifier><AffiliationInfo><Affiliation>Centre for Structural Systems Biology (CSSB), Notkestra&#xdf;e 85, 22607, Hamburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>European Molecular Biology Laboratory (EMBL) Hamburg, Notkestra&#xdf;e 85, 22607, Hamburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Structural and Computational Biology Unit, European Molecular Biology Laboratory, Meyerhofstra&#xdf;e 1, 69117, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf6;w</LastName><ForeName>Christian</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-0764-7483</Identifier><AffiliationInfo><Affiliation>Centre for Structural Systems Biology (CSSB), Notkestra&#xdf;e 85, 22607, Hamburg, Germany. christian.loew@embl-hamburg.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>European Molecular Biology Laboratory (EMBL) Hamburg, Notkestra&#xdf;e 85, 22607, Hamburg, Germany. christian.loew@embl-hamburg.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>4QD397987E</RegistryNumber><NameOfSubstance UI="D006639">Histidine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D048868">Adaptor Proteins, Signal Transducing</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007370">Interferon Type I</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006639" MajorTopicYN="N">Histidine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D048868" MajorTopicYN="N">Adaptor Proteins, Signal Transducing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001327" MajorTopicYN="Y">Autoimmune Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007370" MajorTopicYN="Y">Interferon Type I</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>18</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>15</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>14</Day><Hour>23</Hour><Minute>14</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37709742</ArticleId><ArticleId IdType="pmc">PMC10502012</ArticleId><ArticleId IdType="doi">10.1038/s41467-023-41420-5</ArticleId><ArticleId IdType="pii">10.1038/s41467-023-41420-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Parker JL, et al. Proton movement and coupling in the POT family of peptide transporters. Proc. Natl Acad. Sci. USA. 2017;114:13182&#x2013;13187. doi: 10.1073/pnas.1710727114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1710727114</ArticleId><ArticleId IdType="pmc">PMC5740623</ArticleId><ArticleId IdType="pubmed">29180426</ArticleId></ArticleIdList></Reference><Reference><Citation>Botka CW, et al. Human proton/oligopeptide transporter (POT) genes: identification of putative human genes using bioinformatics. AAPS PharmSci. 2000;2:1&#x2013;22. doi: 10.1208/ps020216.</Citation><ArticleIdList><ArticleId IdType="doi">10.1208/ps020216</ArticleId><ArticleId IdType="pmc">PMC2751030</ArticleId><ArticleId IdType="pubmed">11741232</ArticleId></ArticleIdList></Reference><Reference><Citation>Daniel H, Spanier B, Kottra G, Weitz D. From bacteria to man: archaic proton-dependent peptide transporters at work. Physiology. 2006;21:93&#x2013;102. doi: 10.1152/physiol.00054.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physiol.00054.2005</ArticleId><ArticleId IdType="pubmed">16565475</ArticleId></ArticleIdList></Reference><Reference><Citation>Daniel H, Kottra G. The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology. Pflug. Arch. Eur. J. Physiol. 2004;447:610&#x2013;618. doi: 10.1007/s00424-003-1101-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00424-003-1101-4</ArticleId><ArticleId IdType="pubmed">12905028</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan N. Structural biology of the major facilitator superfamily transporters. Annu. Rev. Biophys. 2015;44:257&#x2013;283. doi: 10.1146/annurev-biophys-060414-033901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-biophys-060414-033901</ArticleId><ArticleId IdType="pubmed">26098515</ArticleId></ArticleIdList></Reference><Reference><Citation>Drew D, North RA, Nagarathinam K, Tanabe M. Structures and general transport mechanisms by the major facilitator superfamily (MFS) Chem. Rev. 2021;121:5289&#x2013;5335. doi: 10.1021/acs.chemrev.0c00983.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.chemrev.0c00983</ArticleId><ArticleId IdType="pmc">PMC8154325</ArticleId><ArticleId IdType="pubmed">33886296</ArticleId></ArticleIdList></Reference><Reference><Citation>Quistgaard EM, L&#xf6;w C, Guettou F, Nordlund P. Understanding transport by the major facilitator superfamily (MFS): Structures pave the way. Nat. Rev. Mol. Cell Biol. 2016;17:123&#x2013;132. doi: 10.1038/nrm.2015.25.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm.2015.25</ArticleId><ArticleId IdType="pubmed">26758938</ArticleId></ArticleIdList></Reference><Reference><Citation>Spanier B, Rohm F. Proton coupled oligopeptide transporter 1 (PepT1) function, regulation, and influence on the intestinal homeostasis. Compr. Physiol. 2018;8:843&#x2013;869. doi: 10.1002/cphy.c170038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cphy.c170038</ArticleId><ArticleId IdType="pubmed">29687907</ArticleId></ArticleIdList></Reference><Reference><Citation>Brandsch M. Drug transport via the intestinal peptide transporter PepT1. Curr. Opin. Pharmacol. 2013;13:881&#x2013;887. doi: 10.1016/j.coph.2013.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coph.2013.08.004</ArticleId><ArticleId IdType="pubmed">24007794</ArticleId></ArticleIdList></Reference><Reference><Citation>Meredith D, Boyd CAR. Structure and function of eukaryotic peptide transporters. Cell. Mol. Life Sci. 2000;57:754&#x2013;778. doi: 10.1007/s000180050040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s000180050040</ArticleId><ArticleId IdType="pubmed">10892342</ArticleId></ArticleIdList></Reference><Reference><Citation>Theis S, et al. Synthesis and characterization of high affinity inhibitors of the H+/peptide transporter PEPT2. J. Biol. Chem. 2002;277:7287&#x2013;7292. doi: 10.1074/jbc.M105028200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M105028200</ArticleId><ArticleId IdType="pubmed">11751927</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamai I, et al. Improvement of L-dopa absorption by dipeptidyl derivation, utilizing peptide transporter PepT1. J. Pharm. Sci. 1998;87:1542&#x2013;1546. doi: 10.1021/js980186o.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/js980186o</ArticleId><ArticleId IdType="pubmed">10189264</ArticleId></ArticleIdList></Reference><Reference><Citation>Ezra A, et al. A peptide prodrug approach for improving bisphosphonate oral absorption. J. Med. Chem. 2000;43:3641&#x2013;3652. doi: 10.1021/jm980645y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm980645y</ArticleId><ArticleId IdType="pubmed">11020278</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y, Song F, Jiang H, Nu&#xf1;ez G, Smith DE. SLC15A2 and SLC15A4 mediate the transport of bacterially- derived Di/Tripeptides to enhance the NOD-dependent immune response in mouse bone marrow-derived macrophages. Physiol. Behav. 2018;201:652&#x2013;662.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6039277</ArticleId><ArticleId IdType="pubmed">29784761</ArticleId></ArticleIdList></Reference><Reference><Citation>Song F, et al. Regulation and biological role of the peptide/histidine transporter SLC15A3 in Toll-like receptor-mediated inflammatory responses in macrophage. Cell Death Dis. 2018;9:1&#x2013;15. doi: 10.1038/s41419-018-0809-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-018-0809-1</ArticleId><ArticleId IdType="pmc">PMC6039463</ArticleId><ArticleId IdType="pubmed">29991810</ArticleId></ArticleIdList></Reference><Reference><Citation>Song F, Hu Y, Wang Y, Smith DE, Jiang H. Functional characterization of human peptide/histidine transporter 1 in stably transfected MDCK cells. Mol. Pharm. 2018;15:385&#x2013;393. doi: 10.1021/acs.molpharmaceut.7b00728.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.molpharmaceut.7b00728</ArticleId><ArticleId IdType="pmc">PMC5826766</ArticleId><ArticleId IdType="pubmed">29224352</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura N, et al. Endosomes are specialized platforms for bacterial sensing and NOD2 signalling. Nature. 2014;509:240&#x2013;244. doi: 10.1038/nature13133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature13133</ArticleId><ArticleId IdType="pubmed">24695226</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhardwaj RK, Herrera-Ruiz D, Eltoukhy N, Saad M, Knipp GT. The functional evaluation of human peptide/histidine transporter 1 (hPHT1) in transiently transfected COS-7 cells. Eur. J. Pharm. Sci. 2006;27:533&#x2013;542. doi: 10.1016/j.ejps.2005.09.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejps.2005.09.014</ArticleId><ArticleId IdType="pubmed">16289537</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang XX, Hu Y, Keep RF, Toyama-Sorimachi N, Smith DE. A Novel Role for PHT1 in the disposition of L-histidine in brain: in vitro slice and in vivo pharmacokinetic studies in wildtype and Pht1 null mice. Biochem. Pharmacol. 2017;124:94&#x2013;102. doi: 10.1016/j.bcp.2016.11.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2016.11.012</ArticleId><ArticleId IdType="pmc">PMC5173442</ArticleId><ArticleId IdType="pubmed">27845049</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakata K, et al. Cloning of a lymphatic peptide/histidine transporter. Biochem. J. 2001;356:53&#x2013;60. doi: 10.1042/bj3560053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bj3560053</ArticleId><ArticleId IdType="pmc">PMC1221811</ArticleId><ArticleId IdType="pubmed">11336635</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan S, Stephansson O, Schi&#xf6;th HB, Fredriksson R. Long evolutionary conservation and considerable tissue specificity of several atypical solute carrier transporters. Gene. 2011;478:11&#x2013;18. doi: 10.1016/j.gene.2010.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2010.10.011</ArticleId><ArticleId IdType="pubmed">21044875</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasius AL, et al. Slc15a4, AP-3, and Hermansky-Pudlak syndrome proteins are required for Toll-like receptor signaling in plasmacytoid dendritic cells. Proc. Natl Acad. Sci. USA. 2010;107:19973&#x2013;19978. doi: 10.1073/pnas.1014051107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1014051107</ArticleId><ArticleId IdType="pmc">PMC2993408</ArticleId><ArticleId IdType="pubmed">21045126</ArticleId></ArticleIdList></Reference><Reference><Citation>Baccala R, et al. Essential requirement for IRF8 and SLC15A4 implicates plasmacytoid dendritic cells in the pathogenesis of lupus. Proc. Natl Acad. Sci. USA. 2013;110:2940&#x2013;2945. doi: 10.1073/pnas.1222798110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1222798110</ArticleId><ArticleId IdType="pmc">PMC3581947</ArticleId><ArticleId IdType="pubmed">23382217</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi T, et al. Lysosome biogenesis regulated by the amino-acid transporter SLC15A4 is critical for functional integrity of mast cells. Int. Immunol. 2017;29:551&#x2013;566. doi: 10.1093/intimm/dxx063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intimm/dxx063</ArticleId><ArticleId IdType="pmc">PMC5890901</ArticleId><ArticleId IdType="pubmed">29155995</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasawatari S, et al. The solute carrier family 15A4 regulates TLR9 and NOD1 functions in the innate immune system and promotes colitis in mice. Gastroenterology. 2011;140:1513&#x2013;1525. doi: 10.1053/j.gastro.2011.01.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2011.01.041</ArticleId><ArticleId IdType="pubmed">21277849</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi T, et al. The histidine transporter SLC15A4 coordinates mTOR-dependent inflammatory responses and pathogenic antibody production. Immunity. 2014;41:375&#x2013;388. doi: 10.1016/j.immuni.2014.08.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2014.08.011</ArticleId><ArticleId IdType="pubmed">25238095</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J, et al. pH-dependent internalization of muramyl peptides from early endosomes enables Nod1 and Nod2 signaling. J. Biol. Chem. 2009;284:23818&#x2013;23829. doi: 10.1074/jbc.M109.033670.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.033670</ArticleId><ArticleId IdType="pmc">PMC2749154</ArticleId><ArticleId IdType="pubmed">19570976</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeuchi F, et al. Search for type 2 diabetes susceptibility genes on chromosomes 1q, 3q and 12q. J. Hum. Genet. 2008;53:314&#x2013;324. doi: 10.1007/s10038-008-0254-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10038-008-0254-6</ArticleId><ArticleId IdType="pubmed">18259684</ArticleId></ArticleIdList></Reference><Reference><Citation>Heinz LX, et al. TASL is the SLC15A4-associated adaptor for IRF5 activation by TLR7&#x2013;9. Nature. 2020;581:316&#x2013;322. doi: 10.1038/s41586-020-2282-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2282-0</ArticleId><ArticleId IdType="pmc">PMC7610944</ArticleId><ArticleId IdType="pubmed">32433612</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S, et al. Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation. Innate Immun. 2015;347:aaa2630.</Citation><ArticleIdList><ArticleId IdType="pubmed">25636800</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen W, et al. Insights into interferon regulatory factor activation from the crystal structure of dimeric IRF5. Nat. Struct. Mol. Biol. 2008;15:1213&#x2013;1220. doi: 10.1038/nsmb.1496.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.1496</ArticleId><ArticleId IdType="pmc">PMC2757928</ArticleId><ArticleId IdType="pubmed">18836453</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao B, et al. Structural basis for concerted recruitment and activation of IRF-3 by innate immune adaptor proteins. Proc. Natl Acad. Sci. USA. 2016;113:E3403&#x2013;E3412. doi: 10.1073/pnas.1603269113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1603269113</ArticleId><ArticleId IdType="pmc">PMC4914169</ArticleId><ArticleId IdType="pubmed">27302953</ArticleId></ArticleIdList></Reference><Reference><Citation>Killer M, Wald J, Pieprzyk J, Marlovits TC, L&#xf6;w C. Structural snapshots of human PepT1 and PepT2 reveal mechanistic insights into substrate and drug transport across epithelial membranes. Sci. Adv. 2021;7:eabk3259. doi: 10.1126/sciadv.abk3259.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abk3259</ArticleId><ArticleId IdType="pmc">PMC8565842</ArticleId><ArticleId IdType="pubmed">34730990</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen J, et al. Extracellular domain of PepT1 interacts with TM1 to facilitate substrate transport. Structure. 2022;30:1035&#x2013;1041. doi: 10.1016/j.str.2022.04.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.str.2022.04.011</ArticleId><ArticleId IdType="pmc">PMC10404463</ArticleId><ArticleId IdType="pubmed">35580608</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker JL, et al. Cryo-EM structure of PepT2 reveals structural basis for proton-coupled peptide and prodrug transport in mammals. Sci. Adv. 2021;7:eabh3355. doi: 10.1126/sciadv.abh3355.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abh3355</ArticleId><ArticleId IdType="pmc">PMC8386928</ArticleId><ArticleId IdType="pubmed">34433568</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindley DJ, Carl SM, Mowery SA, Knipp GT. The evaluation of peptide/histidine Transporter 1 (PHT1) function: uptake kinetics utilizing a COS-7 stably transfected cell line. Rev. Mex. Cienc. Farm. 2011;42:57&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3719411</ArticleId><ArticleId IdType="pubmed">23888104</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamashita T, et al. Cloning and functional expression of a brain peptide/histidine transporter. J. Biol. Chem. 1997;272:10205&#x2013;10211. doi: 10.1074/jbc.272.15.10205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.272.15.10205</ArticleId><ArticleId IdType="pubmed">9092568</ArticleId></ArticleIdList></Reference><Reference><Citation>Temel DB, Landsman P, Brader ML. Orthogonal methods for characterizing the unfolding of therapeutic monoclonal antibodies: differential scanning calorimetry, isothermal chemical denaturation, and intrinsic fluorescence with concomitant static light scattering. Methods Enzymol. 2016;567:359&#x2013;389. doi: 10.1016/bs.mie.2015.08.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.mie.2015.08.029</ArticleId><ArticleId IdType="pubmed">26794361</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander CG, et al. Novel microscale approaches for easy, rapid determination of protein stability in academic and commercial settings. Biochim. Biophys. Acta. 2014;1844:2241&#x2013;2250. doi: 10.1016/j.bbapap.2014.09.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbapap.2014.09.016</ArticleId><ArticleId IdType="pmc">PMC4332417</ArticleId><ArticleId IdType="pubmed">25262836</ArticleId></ArticleIdList></Reference><Reference><Citation>Ericsson UB, Hallberg BM, DeTitta GT, Dekker N, Nordlund P. Thermofluor-based high-throughput stability optimization of proteins for structural studies. Anal. Biochem. 2006;357:289&#x2013;298. doi: 10.1016/j.ab.2006.07.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ab.2006.07.027</ArticleId><ArticleId IdType="pubmed">16962548</ArticleId></ArticleIdList></Reference><Reference><Citation>Killer M, et al. Cryo-EM structure of an atypical proton-coupled peptide transporter: di- and tripeptide permease C. Front. Mol. Biosci. 2022;9:1&#x2013;15. doi: 10.3389/fmolb.2022.917725.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2022.917725</ArticleId><ArticleId IdType="pmc">PMC9309889</ArticleId><ArticleId IdType="pubmed">35898305</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmermann I, et al. Generation of synthetic nanobodies against delicate proteins. Nat. Protoc. 2020;15:1707&#x2013;1741. doi: 10.1038/s41596-020-0304-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41596-020-0304-x</ArticleId><ArticleId IdType="pubmed">32269381</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmermann I, et al. Synthetic single domain antibodies for the conformational trapping of membrane proteins. Elife. 2018;7:1&#x2013;32. doi: 10.7554/eLife.34317.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.34317</ArticleId><ArticleId IdType="pmc">PMC5967865</ArticleId><ArticleId IdType="pubmed">29792401</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson SM, et al. Structural basis of small-molecule inhibition of human multidrug transporter ABCG2. Nat. Struct. Mol. Biol. 2018;25:333&#x2013;340. doi: 10.1038/s41594-018-0049-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41594-018-0049-1</ArticleId><ArticleId IdType="pubmed">29610494</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanson MA, et al. A specific cholesterol binding site is established by the 2.8 &#xc5; structure of the human &#x3b2;2-adrenergic receptor. Structure. 2008;16:897&#x2013;905. doi: 10.1016/j.str.2008.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.str.2008.05.001</ArticleId><ArticleId IdType="pmc">PMC2601552</ArticleId><ArticleId IdType="pubmed">18547522</ArticleId></ArticleIdList></Reference><Reference><Citation>Ung KL, et al. Structures and mechanism of the plant PIN-FORMED auxin transporter. Nature. 2022;609:605&#x2013;610. doi: 10.1038/s41586-022-04883-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04883-y</ArticleId><ArticleId IdType="pmc">PMC9477730</ArticleId><ArticleId IdType="pubmed">35768502</ArticleId></ArticleIdList></Reference><Reference><Citation>Jumper J, et al. Highly accurate protein structure prediction with AlphaFold. Nature. 2021;596:583&#x2013;589. doi: 10.1038/s41586-021-03819-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03819-2</ArticleId><ArticleId IdType="pmc">PMC8371605</ArticleId><ArticleId IdType="pubmed">34265844</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans, R. et al. Protein complex prediction with AlphaFold-Multimer. bioRxiv Prepr. 10.1101/2021.10.04.463034. (2022)</Citation></Reference><Reference><Citation>Yu D, Chojnowski G, Rosenthal M, Kosinski J. AlphaPulldown-a python package for protein-protein interaction screens using AlphaFold-Multimer. Struct. Bioinforma. 2022;39:btac749. doi: 10.1093/bioinformatics/btac749.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btac749</ArticleId><ArticleId IdType="pmc">PMC9805587</ArticleId><ArticleId IdType="pubmed">36413069</ArticleId></ArticleIdList></Reference><Reference><Citation>Karrar S, Cunninghame Graham DS. Abnormal B cell development in systemic lupus erythematosus: what the genetics tell us. Arthritis Rheumatol. 2018;70:496&#x2013;507. doi: 10.1002/art.40396.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.40396</ArticleId><ArticleId IdType="pmc">PMC5900717</ArticleId><ArticleId IdType="pubmed">29207444</ArticleId></ArticleIdList></Reference><Reference><Citation>Katewa A, et al. The peptide symporter SLC15a4 is essential for the development of systemic lupus erythematosus in murine models. PLoS One. 2021;16:e0244439. doi: 10.1371/journal.pone.0244439.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0244439</ArticleId><ArticleId IdType="pmc">PMC7808665</ArticleId><ArticleId IdType="pubmed">33444326</ArticleId></ArticleIdList></Reference><Reference><Citation>Linke P, et al. An automated microscale thermophoresis screening approach for fragment-based lead discovery. J. Biomol. Screen. 2016;21:414&#x2013;421. doi: 10.1177/1087057115618347.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1087057115618347</ArticleId><ArticleId IdType="pmc">PMC4800460</ArticleId><ArticleId IdType="pubmed">26637553</ArticleId></ArticleIdList></Reference><Reference><Citation>Schiebel J, et al. One question, multiple answers: biochemical and biophysical screening methods retrieve deviating fragment hit lists. ChemMedChem. 2015;10:1511&#x2013;1521. doi: 10.1002/cmdc.201500267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cmdc.201500267</ArticleId><ArticleId IdType="pubmed">26259992</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris VM, et al. Characterization of cxorf21 provides molecular insight into female-bias immune response in SLE pathogenesis. Front. Immunol. 2019;10:1&#x2013;11. doi: 10.3389/fimmu.2019.02160.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.02160</ArticleId><ArticleId IdType="pmc">PMC6816314</ArticleId><ArticleId IdType="pubmed">31695690</ArticleId></ArticleIdList></Reference><Reference><Citation>Daniel, L. C. et al. Chemoproteomics-guided development of SLC15A4 inhibitors with anti- inflammatory activity. bioRxiv10.1101/2022.10.07.511216 (2022).</Citation></Reference><Reference><Citation>Bonam SR, Wang F, Muller S. Lysosomes as a therapeutic target. Nat. Rev. Drug Discov. 2019;18:923&#x2013;948. doi: 10.1038/s41573-019-0036-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41573-019-0036-1</ArticleId><ArticleId IdType="pmc">PMC7097195</ArticleId><ArticleId IdType="pubmed">31477883</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, H. et al. SLC15A4 controls endolysosomal TLR7-9 responses by recruiting the innate immune adaptor TASL. Cell Rep. 42, 112916 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37527038</ArticleId></ArticleIdList></Reference><Reference><Citation>Backliwal G, et al. Rational vector design and multi-pathway modulation of HEK 293E cells yield recombinant antibody titers exceeding 1 g/l by transient transfection under serum-free conditions. Nucleic Acids Res. 2008;36:e96. doi: 10.1093/nar/gkn423.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkn423</ArticleId><ArticleId IdType="pmc">PMC2528171</ArticleId><ArticleId IdType="pubmed">18617574</ArticleId></ArticleIdList></Reference><Reference><Citation>Pieprzyk J, Pazicky S, L&#xf6;w C. Transient expression of recombinant membrane-eGFP fusion proteins in HEK293 cells. Methods Mol. Biol. 2018;1850:17&#x2013;31. doi: 10.1007/978-1-4939-8730-6_2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-8730-6_2</ArticleId><ArticleId IdType="pubmed">30242677</ArticleId></ArticleIdList></Reference><Reference><Citation>Cust&#xf3;dio TF, et al. Selection, biophysical and structural analysis of synthetic nanobodies that effectively neutralize SARS-CoV-2. Nat. Commun. 2020;11:5588. doi: 10.1038/s41467-020-19204-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19204-y</ArticleId><ArticleId IdType="pmc">PMC7642358</ArticleId><ArticleId IdType="pubmed">33149112</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheres SHW. RELION: Implementation of a Bayesian approach to cryo-EM structure determination. J. Struct. Biol. 2012;180:519&#x2013;530. doi: 10.1016/j.jsb.2012.09.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsb.2012.09.006</ArticleId><ArticleId IdType="pmc">PMC3690530</ArticleId><ArticleId IdType="pubmed">23000701</ArticleId></ArticleIdList></Reference><Reference><Citation>Punjani A, Rubinstein JL, Fleet DJ, Brubaker MA. CryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods. 2017;14:290&#x2013;296. doi: 10.1038/nmeth.4169.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.4169</ArticleId><ArticleId IdType="pubmed">28165473</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng SQ, et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods. 2017;14:331&#x2013;332. doi: 10.1038/nmeth.4193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.4193</ArticleId><ArticleId IdType="pmc">PMC5494038</ArticleId><ArticleId IdType="pubmed">28250466</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohou A, Grigorieff N. CTFFIND4: fast and accurate defocus estimation from electron micrographs. Struct. Biol. 2015;192:216&#x2013;221. doi: 10.1016/j.jsb.2015.08.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsb.2015.08.008</ArticleId><ArticleId IdType="pmc">PMC6760662</ArticleId><ArticleId IdType="pubmed">26278980</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagner T, et al. SPHIRE-crYOLO is a fast and accurate fully automated particle picker for cryo-EM. Commun. Biol. 2019;2:218. doi: 10.1038/s42003-019-0437-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-019-0437-z</ArticleId><ArticleId IdType="pmc">PMC6584505</ArticleId><ArticleId IdType="pubmed">31240256</ArticleId></ArticleIdList></Reference><Reference><Citation>Pettersen EF, et al. UCSF ChimeraX: structure visualization for researchers, educators, and developers. Protein Sci. 2020;30:70&#x2013;82. doi: 10.1002/pro.3943.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pro.3943</ArticleId><ArticleId IdType="pmc">PMC7737788</ArticleId><ArticleId IdType="pubmed">32881101</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez-Garcia, R. et al. DeepEMhancer: a deep learning solution for cryo-EM volume post-processing. Commun. Biol. 4, 874 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8282847</ArticleId><ArticleId IdType="pubmed">34267316</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams CJ, et al. MolProbity: More and better reference data for improved all-atom structure validation. Protein Sci. 2018;27:293&#x2013;315. doi: 10.1002/pro.3330.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pro.3330</ArticleId><ArticleId IdType="pmc">PMC5734394</ArticleId><ArticleId IdType="pubmed">29067766</ArticleId></ArticleIdList></Reference><Reference><Citation>Emsley P, Lohkamp B, Scott WG, Cowtan K. &amp; IUCr. Features and development of Coot. Acta Crystallogr. Sect. D. Biol. Crystallogr. 2010;66:486&#x2013;501. doi: 10.1107/S0907444910007493.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S0907444910007493</ArticleId><ArticleId IdType="pmc">PMC2852313</ArticleId><ArticleId IdType="pubmed">20383002</ArticleId></ArticleIdList></Reference><Reference><Citation>Croll TI. ISOLDE: A physically realistic environment for model building into low-resolution electron-density maps. Acta Crystallogr. Sect. D. Struct. Biol. 2018;74:519&#x2013;530. doi: 10.1107/S2059798318002425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S2059798318002425</ArticleId><ArticleId IdType="pmc">PMC6096486</ArticleId><ArticleId IdType="pubmed">29872003</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams PD, et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. Sect. D. Biol. Crystallogr. 2010;D66:213&#x2013;221. doi: 10.1107/S0907444909052925.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S0907444909052925</ArticleId><ArticleId IdType="pmc">PMC2815670</ArticleId><ArticleId IdType="pubmed">20124702</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashkenazy H, et al. ConSurf 2016: an improved methodology to estimate and visualize evolutionary conservation in macromolecules. Nucleic Acids Res. 2016;44:W344&#x2013;W350. doi: 10.1093/nar/gkw408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw408</ArticleId><ArticleId IdType="pmc">PMC4987940</ArticleId><ArticleId IdType="pubmed">27166375</ArticleId></ArticleIdList></Reference><Reference><Citation>Pei J, Kim B-H, Grishin NV. PROMALS3D: a tool for multiple protein sequence and structure alignments. Nucleic Acids Res. 2008;36:2295&#x2013;2300. doi: 10.1093/nar/gkn072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkn072</ArticleId><ArticleId IdType="pmc">PMC2367709</ArticleId><ArticleId IdType="pubmed">18287115</ArticleId></ArticleIdList></Reference><Reference><Citation>Bond CS, Sch&#xfc;ttelkopf AW. ALINE: A WYSIWYG protein-sequence alignment editor for publication-quality alignments. Acta Crystallogr. Sect. D. Biol. Crystallogr. 2009;D65:510&#x2013;512. doi: 10.1107/S0907444909007835.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S0907444909007835</ArticleId><ArticleId IdType="pubmed">19390156</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamura K, et al. MEGA5: Molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol. Biol. Evol. 2011;28:2731&#x2013;2739. doi: 10.1093/molbev/msr121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/msr121</ArticleId><ArticleId IdType="pmc">PMC3203626</ArticleId><ArticleId IdType="pubmed">21546353</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryant P, Pozzati G, Elofsson A. Improved prediction of protein-protein interactions using AlphaFold2. Nat. Commun. 2022;13:1265. doi: 10.1038/s41467-022-28865-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-28865-w</ArticleId><ArticleId IdType="pmc">PMC8913741</ArticleId><ArticleId IdType="pubmed">35273146</ArticleId></ArticleIdList></Reference><Reference><Citation>Malhotra S, Joseph AP, Thiyagalingam J, Topf M. Assessment of protein&#x2013;protein interfaces in cryo-EM derived assemblies. Nat. Commun. 2021;12:3399. doi: 10.1038/s41467-021-23692-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-23692-x</ArticleId><ArticleId IdType="pmc">PMC8184972</ArticleId><ArticleId IdType="pubmed">34099703</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotov V, et al. In-depth interrogation of protein thermal unfolding data with MoltenProt. Protein Sci. 2021;30:201&#x2013;217. doi: 10.1002/pro.3986.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pro.3986</ArticleId><ArticleId IdType="pmc">PMC7737771</ArticleId><ArticleId IdType="pubmed">33140490</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall J. A simple model for determining affinity from irreversible thermal shifts. Protein Sci. 2019;28:1880&#x2013;1887. doi: 10.1002/pro.3701.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pro.3701</ArticleId><ArticleId IdType="pmc">PMC6739816</ArticleId><ArticleId IdType="pubmed">31361943</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotov, V. et al. Plasticity of the binding pocket in peptide transporters underpins promiscuous substrate recognition. Cell Rep. 42, 112831 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37467108</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>